Field collection and preservation of urine in orangutans and chimpanzees

Poster presented at the American Association of Physical Anthropologists Meeting, Durham, North Carolina, April 14, 1996Disease is recognized as a critical factor that can affect primate behavior, yet few methods allow for the quantification of disease states in wild primates. This paper reports on the use of urinary test strips to detect the presence of disease and monitor physiological status in wild orangutans . Urine was collected from wild orangutans at Gunung Palung National Park, Indonesian Borneo, between August 1994 and August 1995. A total of 387 urine samples were obtained from over 43 orangutans by placing plastic sheets beneath individuals during urination. Boehringer Mannheim urinary test strips were used to evaluate specific gravity, leukocytes, nitrite, pH, ketones, protein, glucose, urobilinogen, bilirubin and blood . Objectives of using these test strips were (1) to evaluate the presence of disease (2) to detect signs of nutritional stress (3) to monitor the occurrence of menstruation and (4) to use specific gravity as a measure of urine concentration for hormonal analysis. [TRUNCATED

Are male orangutans a threat to infants? Evidence of mother-offspring counter strategies to infanticide in Bornean orangutans (Pongo pygmaeus wurmbii)

Sexually selected infanticide by males is widespread in primates. Female primates employ a variety of strategies to reduce infanticide risk. While infanticide has never been directly observed in wild orangutans (Pongo spp.), their slow life history makes infants vulnerable to infanticide. The mating strategies of female orangutans include polyandrous and postconceptive mating that may serve to increase paternity confusion, an infanticide avoidance strategy. Here, we investigate whether female orangutans alter their social interactions with males as another infanticide avoidance strategy. We hypothesize that females with younger offspring avoid males and that the distance between mother and offspring decreases in the presence of males. We use long-term behavioral data collected between 1994 and 2016 from Bornean orangutans (Pongo pygmaeus wurmbii) in Gunung Palung National Park, Indonesia, to test whether the sexual selection hypothesis for infanticide helps explain aspects of orangutan social behavior. We found that mothers with offspring 6 yr. old and females without offspring. In addition, the distance between a mother–offspring dyad showed a statistically significant decrease in the presence of males, but not females. Our results are consistent with the hypothesis that female orangutans employ strategies to reduce infanticide risk in their social interactions. Because orangutans have a high fission–fusion dynamic, they have flexibility in manipulating social interactions as a counter-infanticide strategy. Our results suggest that infanticide by males is a selective pressure shaping female orangutan social behavior.Accepted manuscrip

Possible male infanticide in wild orangutans and a re-evaluation of infanticide risk

Infanticide as a male reproductive tactic is widespread across mammals, and is particularly prevalent in catarrhine primates. While it has never been observed in wild orangutans, infanticide by non-sire males has been predicted to occur due to their extremely long inter-birth intervals, semi-solitary social structure, and the presence of female counter-tactics to infanticide. Here, we report on the disappearance of a healthy four-month-old infant, along with a serious foot injury suffered by the primiparous mother. No other cases of infant mortality have been observed at this site in 30 years of study. Using photographic measurements of the injury, and information on the behavior and bite size of potential predators, we evaluate the possible causes of this injury. The context, including the behavior of the female and the presence of a new male at the time of the injury, lead us to conclude that the most likely cause of the infant loss and maternal injury was male infanticide. We suggest that in orangutans, and other species where nulliparous females are not preferred mates, these females may be less successful at using paternity confusion as an infanticide avoidance tactic, thus increasing the likelihood of infanticide of their first-born infants.Published versio

Wild Bornean orangutans (Pongo pygmaeus wurmbii) navigate to non-fruit foods

Accepted manuscrip

Habituation, avoidance strategies, and social learning in wild Bornean Orangutans in Gunung Palung National Park, Indonesia

https://onlinelibrary.wiley.com/doi/10.1002/ajpa.24023Published versio

Population-specific use of the same tool-assisted alarm call between two wild orangutan populations (Pongopygmaeus wurmbii) indicates functional arbitrariness

This study was financially supported by Fundação para a Ciência e Tecnologia (SFRH/BD/44437/2008), Wenner-Gren Foundation for Anthropological Research, Dr. J.L. Dobberke voor Vergelijkende Psychologie, Lucie Burgers Foundation for Comparative Behaviour Research, Schure-Beijerinck-Popping Fonds, Ruggles-Gates Fund for Anthropological Scholarship of the Royal Anthropological Institute of Great Britain and Ireland, and Fundação Calouste Gulbenkian. KN and ET were financially supported by Pongo Foundation. Orangutan fieldwork at Cabang Panti was supported by grants to CDK from the 16 National Science Foundation (0936199), the National Geographic Society, the Leakey Foundation and the US Fish and Wildlife Service.Arbitrariness is an elementary feature of human language, yet seldom an object of comparative inquiry. While arbitrary signals for the same function are relatively frequent between animal populations across taxa, the same signal with arbitrary functions is rare and it remains unknown whether, in parallel with human speech, it may involve call production in animals. To investigate this question, we examined a particular orangutan alarm call - the kiss-squeak - and two variants - hand and leaf kiss-squeaks. In Tuanan (Central Kalimantan, Indonesia), the acoustic frequency of unaided kiss-squeaks is negatively related to body size. The modified variants are correlated with perceived threat and are hypothesized to increase the perceived body size of the sender, as the use of a hand or leaves lowers the kiss-squeak's acoustic frequency. We examined the use of these variants in the same context in another orangutan population of the same sub-species and with partially similar habitat at Cabang Panti (West Kalimantan, Indonesia). Identical analyses of data from this site provided similar results for unaided kiss-squeaks but dissimilar results for hand and leaf kiss-squeaks. Unaided kiss-squeaks at Cabang Panti were emitted as commonly and showed the same relationship to body size as in Tuanan. However, at Cabang Panti, hand kiss-squeaks were extremely rare, while leaf-use neither conveyed larger body size nor was related to perceived threat. These findings indicate functional discontinuity between the two sites and therefore imply functional arbitrariness of leaf kiss-squeaks. These results show for the first time the existence of animal signals involving call production with arbitrary function. Our findings are consistent with previous studies arguing that these orangutan call variants are socially learned and reconcile the role of gestures and calls within evolutionary theories based on common ancestry for speech and music.Publisher PDFPeer reviewe

Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease

BACKGROUND: Patients with atherosclerotic vascular disease remain at high risk for cardiovascular events despite effective statin-based treatment of low-density lipoprotein (LDL) cholesterol levels. The inhibition of cholesteryl ester transfer protein (CETP) by anacetrapib reduces LDL cholesterol levels and increases high-density lipoprotein (HDL) cholesterol levels. However, trials of other CETP inhibitors have shown neutral or adverse effects on cardiovascular outcomes. METHODS: We conducted a randomized, double-blind, placebo-controlled trial involving 30,449 adults with atherosclerotic vascular disease who were receiving intensive atorvastatin therapy and who had a mean LDL cholesterol level of 61 mg per deciliter (1.58 mmol per liter), a mean non-HDL cholesterol level of 92 mg per deciliter (2.38 mmol per liter), and a mean HDL cholesterol level of 40 mg per deciliter (1.03 mmol per liter). The patients were assigned to receive either 100 mg of anacetrapib once daily (15,225 patients) or matching placebo (15,224 patients). The primary outcome was the first major coronary event, a composite of coronary death, myocardial infarction, or coronary revascularization. RESULTS: During the median follow-up period of 4.1 years, the primary outcome occurred in significantly fewer patients in the anacetrapib group than in the placebo group (1640 of 15,225 patients [10.8%] vs. 1803 of 15,224 patients [11.8%]; rate ratio, 0.91; 95% confidence interval, 0.85 to 0.97; P=0.004). The relative difference in risk was similar across multiple prespecified subgroups. At the trial midpoint, the mean level of HDL cholesterol was higher by 43 mg per deciliter (1.12 mmol per liter) in the anacetrapib group than in the placebo group (a relative difference of 104%), and the mean level of non-HDL cholesterol was lower by 17 mg per deciliter (0.44 mmol per liter), a relative difference of -18%. There were no significant between-group differences in the risk of death, cancer, or other serious adverse events. CONCLUSIONS: Among patients with atherosclerotic vascular disease who were receiving intensive statin therapy, the use of anacetrapib resulted in a lower incidence of major coronary events than the use of placebo. (Funded by Merck and others; Current Controlled Trials number, ISRCTN48678192 ; ClinicalTrials.gov number, NCT01252953 ; and EudraCT number, 2010-023467-18 .)

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

BACKGROUND: A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four trials. METHODS: This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Africa. Participants aged 18 years and older were randomly assigned (1:1) to ChAdOx1 nCoV-19 vaccine or control (meningococcal group A, C, W, and Y conjugate vaccine or saline). Participants in the ChAdOx1 nCoV-19 group received two doses containing 5 × 1010 viral particles (standard dose; SD/SD cohort); a subset in the UK trial received a half dose as their first dose (low dose) and a standard dose as their second dose (LD/SD cohort). The primary efficacy analysis included symptomatic COVID-19 in seronegative participants with a nucleic acid amplification test-positive swab more than 14 days after a second dose of vaccine. Participants were analysed according to treatment received, with data cutoff on Nov 4, 2020. Vaccine efficacy was calculated as 1 - relative risk derived from a robust Poisson regression model adjusted for age. Studies are registered at ISRCTN89951424 and ClinicalTrials.gov, NCT04324606, NCT04400838, and NCT04444674. FINDINGS: Between April 23 and Nov 4, 2020, 23 848 participants were enrolled and 11 636 participants (7548 in the UK, 4088 in Brazil) were included in the interim primary efficacy analysis. In participants who received two standard doses, vaccine efficacy was 62·1% (95% CI 41·0-75·7; 27 [0·6%] of 4440 in the ChAdOx1 nCoV-19 group vs71 [1·6%] of 4455 in the control group) and in participants who received a low dose followed by a standard dose, efficacy was 90·0% (67·4-97·0; three [0·2%] of 1367 vs 30 [2·2%] of 1374; pinteraction=0·010). Overall vaccine efficacy across both groups was 70·4% (95·8% CI 54·8-80·6; 30 [0·5%] of 5807 vs 101 [1·7%] of 5829). From 21 days after the first dose, there were ten cases hospitalised for COVID-19, all in the control arm; two were classified as severe COVID-19, including one death. There were 74 341 person-months of safety follow-up (median 3·4 months, IQR 1·3-4·8): 175 severe adverse events occurred in 168 participants, 84 events in the ChAdOx1 nCoV-19 group and 91 in the control group. Three events were classified as possibly related to a vaccine: one in the ChAdOx1 nCoV-19 group, one in the control group, and one in a participant who remains masked to group allocation. INTERPRETATION: ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials. FUNDING: UK Research and Innovation, National Institutes for Health Research (NIHR), Coalition for Epidemic Preparedness Innovations, Bill & Melinda Gates Foundation, Lemann Foundation, Rede D'Or, Brava and Telles Foundation, NIHR Oxford Biomedical Research Centre, Thames Valley and South Midland's NIHR Clinical Research Network, and AstraZeneca